Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

BVMF/DVAI34 stock hub

BVMF/DVAI34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVMF/DVAI34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
62.5B
Brazil Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BVMF/DVAI34
In the news

Latest news · BVMF/DVAI34

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.9
P25 11.3P50 14.6P75 19.6
Trailing P/E15.3
P25 15.2P50 21.5P75 27.3
ROE81
P25 5.3P50 12.3P75 22.5
ROIC12.1
P25 7P50 12.5P75 22.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVMF/DVAI34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
212
Groups with data
11
Currency
USD
Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
BR
Employees
78,000
Employees Change
6,000%
Employees Change Percent
8.57
Enterprise value
BRL 132.8B
Exchange
Brazil Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Medical Care Facilities
Last refreshed
2026-05-10
Market cap
BRL 62.5B
Price
BRL 955
Price currency
BRL
Rev Per Employee
925,305.76x
Sector
Healthcare
Sic
8090
Symbol
bvmf/DVAI34
Website
https://www.davita.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
6.53%
EV Earnings
32.57x
EV/EBIT
12.84x
EV/EBITDA
7.67x
EV/FCF
17.05x
EV/Sales
1.96x
FCF yield
12.47%
Forward P/E
12.86x
P/B ratio
11.42x
P/E ratio
15.32x
P/S ratio
0.87x
PE Ratio10 Y
19.21x
PE Ratio3 Y
14.15x
PE Ratio5 Y
13.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
15.01%
EBITDA Margin
20.19%
FCF margin
10.79%
Gross margin
32.45%
Gross Profit
BRL 23.4B
Gross Profit Growth
6.67%
Gross Profit Growth Q
9.09%
Gross Profit Growth3 Y
9.54%
Gross Profit Growth5 Y
4.65%
Net Income
BRL 4.1B
Net Income Growth
-9.1%
Net Income Growth Q
21.25%
Net Income Growth3 Y
15%
Net Income Growth5 Y
0.26%
Pretax Margin
10.13%
Profit Margin
5.65%
Profit Per Employee
BRL 52,262
ROA
7.5
Roa5y
6.34
ROCE
14.19
ROE
80.98
Roe5y
46.91
ROIC
12.06
Roic5y
10.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr1y
15.34%
Cagr3y
29.4%
Cagr5y
7.93%
EPS Growth
6.22
EPS Growth Q
43.5
EPS Growth3 Y
25.13
EPS Growth5 Y
10.67
FCF Growth
-15.15%
FCF Growth Q
495.39%
FCF Growth3 Y
11.5%
FCF Growth5 Y
6.13%
OCF Growth
-13.25%
OCF Growth Q
78.23%
OCF Growth10 Y
2.55%
OCF Growth3 Y
5.94%
OCF Growth5 Y
2.72%
Revenue Growth
6.68x
Revenue Growth Q
5.96x
Revenue Growth3 Y
5.85x
Revenue Growth5 Y
3.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
BRL 0.8
Assets
BRL 91.3B
Cash
BRL 3.5B
Current Assets
BRL 20B
Current Liabilities
BRL 14.1B
Debt
BRL 69B
Debt EBITDA
BRL 3.78
Debt Equity
BRL 12.61
Debt FCF
BRL 8.86
Equity
BRL 5.5B
Interest Coverage
3.59
Liabilities
BRL 85.8B
Long Term Assets
BRL 71.3B
Long Term Liabilities
BRL 71.7B
Net Cash
BRL -65.5B
Net Cash By Market Cap
BRL -105
Net Debt EBITDA
BRL 4.5
Net Debt Equity
BRL 11.98
Net Debt FCF
BRL 8.41
Tangible Book Value
BRL -44.7B
Tangible Book Value Per Share
BRL -675
WACC
6.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.42
Inventory Turnover
63.98
Net Working Capital
BRL 5.6B
Quick ratio
1.28
Working Capital
BRL 6.2B
Working Capital Turnover
BRL 75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
14.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
15.33%
200-day SMA
813
3Y total return
116.69%
50-day SMA
785.9
50-day SMA vs 200-day SMA
50under200
5Y total return
46.43%
All Time High
1,047.5
All Time High Change
-8.86%
All Time High Date
2025-01-30
All Time Low
171.7
All Time Low Change
455.99%
All Time Low Date
2019-05-31
ATR
25.38
Beta
0.92
Ch YTD
46.76
High
966.9
High52
972.5
High52 Date
2026-05-08
High52ch
-1.26%
Low
927
Low52
546.6
Low52 Date
2026-01-14
Low52ch
74.66%
Ma50ch
21.49%
Price vs 200-day SMA
17.43%
RSI
81.41
RSI Monthly
63.75
RSI Weekly
67.13
Sharpe ratio
0.75x
Sortino ratio
1.42
Total Return
14.33%
Tr YTD
46.76
Tr1m
23.5%
Tr1w
23.45%
Tr3m
28.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
BRL 10.8B
Operating Income Growth
6.67
Operating Income Growth Q
9.28
Operating Income Growth3 Y
17.31
Operating Income Growth5 Y
4
Operating margin
15.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
33,852,221%
Net Borrowing
4,335,813,402.6
Shares Insiders
2.24%
Shares Institutions
54.35%
Shares Qo Q
-3.35%
Shares Yo Y
-14.33%
Short Ratio
6.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
BRL 7.1B
Average Volume
18.6x
Bv Per Share
-59.55
CAPEX
BRL -2.8B
Ch1m
23.5
Ch1w
23.45
Ch1y
15.33
Ch3m
28.37
Ch3y
116.7
Ch5y
46.43
Ch6m
52.94
Change
1.06%
Change From Open
2.99
Close
944.7
Days Gap
-1.87
Depreciation Amortization
3,522,134,909.2
Dollar Volume
8,592.5
Earnings Date
2026-05-05
EBIT
BRL 10.8B
EBITDA
BRL 14.6B
EPS
BRL 56.03
F Score
6
FCF
BRL 7.8B
FCF EV Yield
5.86x
Financing CF
-6,289,194,976
Fiscal Year End
December
Founded
1,994
Goodwill
37,261,002,544.6
Graham Number
342.30599
Graham Upside
-64.15
Income Tax
BRL 1.6B
Investing CF
-3,296,458,961
Is Primary Listing
0
Last Earnings Date
2026-05-05
Last Report Date
2026-03-31
Lynch Fair Value
BRL 312
Lynch Upside
-67.37
Ma150
768.6
Ma150ch
24.21%
Ma20
785.7
Ma20ch
21.51%
Net CF
1,052,891,607
Open
927
P FCF Ratio
8.02
P OCF Ratio
5.91
Position In Range
69.47
Ppne
25,315,265,418.4
Price Date
2026-05-07
Price EBITDA
BRL 4.29
Relative Volume
0.85x
Revenue
72,173,849,447x
SBC By Revenue
1x
Share Based Comp
721,754,771
Tax By Revenue
2.21x
Tax Rate
21.77%
Tr6m
52.94%
Volume
9
Z Score
1.6
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BVMF/DVAI34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/DVAI34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+15.3%
S&P 500 1Y: n/a
3Y total return
+116.7%
S&P 500 3Y: n/a
5Y total return
+46.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BVMF/DVAI34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+54.4%
Share of float held by funds and institutions
Insider ownership
+2.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
6.7 days to cover
Y/Y dilution
-14.3%
Negative means the company is buying back shares.
Technical

BVMF/DVAI34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
81.4
Above 70: short-term overbought
Price vs 200-day MA
+17.4%
50/200-day relationship not available
Beta (5Y)
0.92
Moves roughly with the market
Sharpe ratio
0.75
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVMF/DVAI34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/DVAI34 stock rating?

bvmf/DVAI34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/DVAI34 analysis?

The full report lives at /stocks/bvmf/DVAI34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/DVAI34?

The latest report frames bvmf/DVAI34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/DVAI34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bvmf/DVAI34 stock profile: metrics, valuation and analysis | دستیار هوشمند بازار سهام